- Home
- SLBT vs UROY Comparison
SLBT vs UROY Comparison
Compare SLBT & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SLBT | UROY |
|---|---|---|
| Founded | N/A | 2017 |
| Country | Taiwan | Canada |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2025 | 2026 |
Fundamental Metrics
Financial Performance| Metric | SLBT | UROY |
|---|---|---|
| Price | $2.69 | $4.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 72.2K | ★ 3.2M |
| Earning Date | N/A | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $279.20 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1,584.46 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.54 | $2.56 |
| 52 Week High | $6.25 | $5.52 |
Technical Indicators
Market Signals| Indicator | SLBT | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 40.10 | 72.81 |
| Support Level | $2.54 | $3.54 |
| Resistance Level | $3.40 | $4.48 |
| Average True Range (ATR) | 0.17 | 0.23 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 0.00 | 94.55 |
Price Performance
Historical ComparisonAbout SLBT SL Science Holding Limited Ordinary Shares
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.